HartMH, VanderhoofJA, AntonsonDL. Failure of blind small bowel biopsy in the diagnosis of intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr.1987; 6: 803–805.
2.
UguralpS, MutusM, KutluO, CetinS, BaysalT, MizrakB. Primary intestinal lymphangiectasia: a rare disease in the differential diagnosis of acute abdomen. J Pediatr Gastroenterol Nutr.2001; 33: 508–510.
3.
DumlerJS, BaisdenBL, YardleyJH, RaoultD. Immu-nodetection of Tropheryma whipplei in intestinal tissues from Dr. Whipple's 1907 patient. N Engl J Med.2003; 348: 1411–1412.
4.
MartinDF, MontgomeryE, DobekAS, PatrissiGA, PeuraDA. Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol.1989; 84: 1268–1272.
5.
MarshallBJ, WarrenJR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet.1984; 1: 1311–1315.
6.
RiddellRH. Pathobiology of Helicobacter pylori infection in children. Can J Gastroenterol.1999; 13: 599–603.
7.
TriadafilopoulosG. Clinical and pathologic features of the nodular duodenum. Am J Gastroenterol.1993; 88: 1058–1064.
8.
ShekitkaKM, HelwigEB. Deceptive bizarre stromal cells in polyps and ulcers of the gastrointestinal tract. Cancer.1991; 67: 2111–2117.
9.
WeisdorfDJ, SnoverDC, HaakeR. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood.1990; 76: 624–629.
10.
RoyJ, SnoverD, WeisdorfS, MulvahillA, FilipovichA, WeisdorfD. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation.1991; 51: 642–646.
11.
SnoverDC, WeisdorfSA, VercellottiGM, RankB, HuttonS, McGlaveP. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol.1985; 16: 387–392.
12.
Cruz-CorreaM, PoonawalaA, AbrahamSC. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease. Endoscopy.2002; 34: 808–813.
13.
NguyenT, ParkJY, ScudiereJR, MontgomeryE. Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract. Am J Surg Pathol.2009; 33: 1355–1363.
14.
PapadimitriouJC, CangroCB, LustbergA. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol.2003; 11: 295–302.
ObleDA, Mino-KenudsonM, GoldsmithJ. Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis. Am J Surg Pathol.2008; 32: 1130–1137.
17.
JohnsonTC, DiamondB, MemeoL. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol.2004; 2: 888–894.
18.
CarlssonA, AxelssonI, BorulfS. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome. Pediatrics.1998; 101: 272–275.
19.
MakiM, MustalahtiK, KokkonenJ. Prevalence of celiac disease among children in Finland. N Engl J Med.2003; 348: 2517–2524.
20.
FasanoA, BertiI, GerarduzziT. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med.2003; 163: 286–292.
21.
FasanoA. European and North American populations should be screened for coeliac disease. Gut.2003; 52: 168–169.
22.
CatassiC, RatschIM, GandolfiL. Why is coeliac disease endemic in the people of the Sahara?Lancet.1999; 354: 647–648.
23.
RostamiK, MalekzadehR, ShahbazkhaniB, AkbariMR, CatassiC. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder?Dig Liver Dis.2004; 36: 694–697.
24.
CatassiC, FasanoA. Celiac disease as a cause of growth retardation in childhood. Curr Opin Pediatr.2004; 16: 445–449.
25.
MarshMN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroen-terology.1992; 102: 330–354.
26.
RostamiK, KerckhaertJ, TiemessenR, von BlombergBM, MeijerJW, MulderCJ. Sensitivity of antiendomy-sium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol.1999; 94: 888–894.
27.
RostamiK, KerckhaertJP, TiemessenR, MeijerJW, MulderCJ. The relationship between anti-endomysium antibodies and vil-lous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol.1999; 11: 439–442.
28.
MinoM, LauwersGY. Role of lymphocytic immunophenotyping in the diagnosis of gluten-sensitive enteropathy with preserved villous architecture. Am J Surg Pathol.2003; 27: 1237–1242.
29.
WashingtonK, StenzelTT, BuckleyRH, GottfriedMR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol.1996; 20: 1240–1252.
30.
DanielsJA, LedermanHM, MaitraA, MontgomeryEA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol.2007; 31: 1800–1812.
Blanco QuirosA, Arranz SanzE, Bernardo OrdizD, Garrote AdradosJA. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome. Allergol Immunopathol (Madr).2009; 37: 208–215.
33.
d'HennezelE, Ben-ShoshanM, OchsHD. FOXP3 fork-head domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med.2009; 361: 1710–1713.
34.
Oliva-HemkerM, BerkenblitGV, AnhaltGJ, YardleyJH. Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption. J Clin Endocrinol Metab.2006; 91: 2833–2838.
